GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Pharmaceutical (XKRX:001060) » Definitions » Cyclically Adjusted PB Ratio

JW Pharmaceutical (XKRX:001060) Cyclically Adjusted PB Ratio : 1.98 (As of Jun. 04, 2025)


View and export this data going back to 1976. Start your Free Trial

What is JW Pharmaceutical Cyclically Adjusted PB Ratio?

As of today (2025-06-04), JW Pharmaceutical's current share price is ₩23000.00. JW Pharmaceutical's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was ₩11,613.25. JW Pharmaceutical's Cyclically Adjusted PB Ratio for today is 1.98.

The historical rank and industry rank for JW Pharmaceutical's Cyclically Adjusted PB Ratio or its related term are showing as below:

XKRX:001060' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.53   Med: 2.55   Max: 4.02
Current: 2

During the past years, JW Pharmaceutical's highest Cyclically Adjusted PB Ratio was 4.02. The lowest was 1.53. And the median was 2.55.

XKRX:001060's Cyclically Adjusted PB Ratio is ranked worse than
50.72% of 696 companies
in the Drug Manufacturers industry
Industry Median: 1.975 vs XKRX:001060: 2.00

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

JW Pharmaceutical's adjusted book value per share data for the three months ended in Mar. 2025 was ₩14,231.786. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₩11,613.25 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


JW Pharmaceutical Cyclically Adjusted PB Ratio Historical Data

The historical data trend for JW Pharmaceutical's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW Pharmaceutical Cyclically Adjusted PB Ratio Chart

JW Pharmaceutical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.01 2.04 1.65 3.18 2.10

JW Pharmaceutical Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.89 2.69 2.43 2.10 1.79

Competitive Comparison of JW Pharmaceutical's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, JW Pharmaceutical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JW Pharmaceutical's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JW Pharmaceutical's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where JW Pharmaceutical's Cyclically Adjusted PB Ratio falls into.


;
;

JW Pharmaceutical Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

JW Pharmaceutical's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=23000.00/11613.25
=1.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JW Pharmaceutical's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, JW Pharmaceutical's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=14231.786/122.5900*122.5900
=14,231.786

Current CPI (Mar. 2025) = 122.5900.

JW Pharmaceutical Quarterly Data

Book Value per Share CPI Adj_Book
201506 9,906.458 100.051 12,138.173
201509 9,950.956 100.111 12,185.376
201512 10,223.434 100.220 12,505.346
201603 9,843.259 100.561 11,999.546
201606 9,139.566 100.791 11,116.297
201609 10,814.689 101.461 13,066.795
201612 11,063.283 101.561 13,353.983
201703 10,700.221 102.851 12,753.840
201706 10,665.479 102.611 12,742.077
201709 10,858.629 103.491 12,862.623
201712 10,849.461 102.991 12,914.119
201803 10,710.384 104.101 12,612.641
201806 11,168.886 104.130 13,148.850
201809 11,308.885 105.651 13,122.098
201812 10,486.576 104.351 12,319.509
201903 10,192.671 104.491 11,958.166
201906 10,254.122 104.881 11,985.527
201909 10,302.648 105.200 12,005.685
201912 9,515.185 105.121 11,096.386
202003 8,823.846 105.354 10,267.415
202006 8,498.347 105.112 9,911.469
202009 8,646.492 106.198 9,981.143
202012 9,018.341 105.765 10,452.931
202103 8,626.615 107.357 9,850.636
202106 8,473.862 107.579 9,656.295
202109 8,716.016 108.759 9,824.423
202112 8,740.544 109.676 9,769.680
202203 8,583.375 111.848 9,407.731
202206 8,651.003 114.072 9,296.967
202209 9,047.924 114.715 9,669.024
202212 10,036.563 115.179 10,682.330
202303 10,377.237 116.507 10,919.010
202306 10,986.949 117.182 11,493.992
202309 10,217.645 118.964 10,529.112
202312 11,327.550 118.837 11,685.276
202403 11,526.005 120.123 11,762.698
202406 11,875.469 120.007 12,131.043
202409 12,737.574 120.861 12,919.772
202412 14,031.564 121.135 14,200.079
202503 14,231.786 122.590 14,231.786

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


JW Pharmaceutical  (XKRX:001060) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


JW Pharmaceutical Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of JW Pharmaceutical's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


JW Pharmaceutical Business Description

Traded in Other Exchanges
Address
2477, Nambusunhwan-ro, Seocho-gu, KOR
JW Pharmaceutical is active in the healthcare sector. It has been one of the leading companies in the pharmaceutical market on a global basis. Its original medicine and medical supply pipeline include Livalo, Thrupas, Sigmart and Actemra. It also develops low-protein and low-salt diet food for patients suffering from chronic renal insufficiency as well as general Pharmaceuticals and health care products.

JW Pharmaceutical Headlines

No Headlines